Dr. Brian Jamieson joined Dova Pharmaceuticals in 2017 as Vice President of Clinical Operations. With more than ten years of clinical experience in the development and approval of pharmaceuticals, Brian has been instrumental in driving the clinical development of avatrombopag resulting in multiple regulatory approvals. He is currently leading development efforts in additional indications and for pediatric patients. 

Before joining Dova, Brian served as Executive Director of Clinical Research at Cempra Pharmaceuticals where he was responsible for the clinical development of anti-infective agents. Brian received his M.D. from the University of Texas – Southwestern Medical School, completed a surgical internship and anesthesiology residency at the University of California, San Diego, and was a staff anesthesiologist for several years in private practice before entering the pharmaceutical industry.  

Brian earned his B.S. in chemistry, biochemistry, and biology from Rice University.